Spots Global Cancer Trial Database for Study Evaluating HKI-272 Administered to Healthy Subjects
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Trial Identification
Brief Title: Study Evaluating HKI-272 Administered to Healthy Subjects
Official Title: Ascending Single Dose Study of the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of HKI-272 Administered Orally to Healthy Subjects.
Study ID: NCT00366600
Conditions
Interventions
Study Description
Brief Summary: Safety and tolerability of HKI-272 in healthy subjects; the influence of food intake on the same.
Detailed Description:
Eligibility
Minimum Age: 18 Years
Eligible Ages: ADULT
Sex: ALL
Healthy Volunteers: Yes
Locations
Northwest Kinetics, Tacoma, Washington, United States
Contact Details
Name: Puma
Affiliation: Biotechnology
Role: STUDY_DIRECTOR
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
